@article{4fb3533aa30b409ebe16e2cad97e9d98,
title = "The TB structural genomics consortium: Providing a structural foundation for drug discovery",
abstract = "Structural genomics, the large-scale determination of protein structures, promises to provide a broad structural foundation for drug discovery. The tuberculosis (TB) Structural Genomics Consortium is devoted to encouraging, coordinating, and facilitating the determination of structures of proteins from Mycobacterium tuberculosis and hopes to determine 400 TB protein structures over 5 years. The Consortium has determined structures of 28 proteins from TB to date. These protein structures are already providing a basis for drug discovery efforts.",
keywords = "controlled study, disulfide bond, drug research, drug targeting, Mycobacterium tuberculosis, protein analysis, protein structure, structural gene, drug design",
author = "{The TB Structural Genomics Consortium} and Lott, {J. Shaun} and Terwilliger, {Thomas C.} and William Jacobs and Bernhard Rupp and Tom Alber and James Sacchettini and David Eisenberg and Park, {Min S.} and Vivek Sharma and Joel Berendzen and Munro, {Andrew W.} and McLean, {Kirsty J.} and David Leys and Arcus, {Vickery L.} and Baker, {Edward N.} and Goulding, {Celia W.} and Johnston, {Jodie M.} and Mande, {Shekhar C.} and Nandita Bachhawat and Avinash Kale and Radha Chauhan and {Won Suh}, Se and Waldo, {Geoffrey S.} and Jin KukYang and Kuo, {Mack R.} and Smith, {Clare V.} and Gill, {Harindarpal S.} and Anderson, {Daniel H.} and Marcin Apostol",
year = "2002",
doi = "10.2174/1568005023342551",
language = "English",
volume = "2",
pages = "121--141",
journal = "Infectious Disorders - Drug Targets",
issn = "1871-5265",
publisher = "Bentham Science Publishers B.V.",
number = "2",
}
